Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration.
Cheng X, Zhang G, Zhang L, Hu Y, Zhang K, Sun X, Zhao C, Li H, Li YM, Zhao J. · 2018
Read Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. by Cheng X, Zhang G, Zhang L, Hu Y, Zhang K, Sun X, Zhao C, Li H, Li YM, Zhao J. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5742691.txt.
Introduction
Cheng and co-authors study how stem cell exosomes protect disc cells in the spine. The soft center of each disc loses cells as discs wear down. Mesenchymal stem cells can slow that loss, for unclear reasons. The team tested tiny packets, called exosomes, that these stem cells release.
The packets entered disc cells and held back their death, they report. The packets carry miR-21, a small RNA scarce in dying disc cells. MiR-21 blocks PTEN and switches on a survival path in the cells. Injecting the packets into rat discs eased cell death and disc wear.
Catalog record
| CREATOR | Cheng X, Zhang G, Zhang L, Hu Y, Zhang K, Sun X, Zhao C, Li H, Li YM, Zhao J. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mesenchymal stem cells deliver exogenous miR‐21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration By Xiaofei Cheng, Guoying Zhang, Liang Zhang, Ying Hu, Kai Zhang, Xiaojiang Sun, Changqing Zhao, Hua Li, Yan Michael Li, Jie Zhao Published in: Journal of Cellular and Molecular Medicine DOI: 10.1111/jcmm.13316 ABSTRACT Abstract Although mesenchymal stem cells (MSCs) transplantation into the IVD (intervertebral disc) may be beneficial in inhibiting apoptosis of nucleus pulposus cells (NPCs) and alleviating IVD degeneration, the underlying mechanism of this therapeutic process has not been fully explained. The purpose of this study was to explore the protective effect of MSC‐derived exosomes (MSC‐exosomes) on NPC apoptosis and IVD degeneration and investigate the regulatory effect of miRNAs in MSC‐exosomes and associated mechanisms for NPC apoptosis. MSC‐exosomes were isolated from MSC medium, and its anti‐apoptotic effect was assessed in a cell and rat model. The down‐regulated miRNAs in apoptotic NPCs were identified, and their contents in MSC‐exosomes were detected. The target genes of eligible miRNAs and possible downstream pathway were investigated. Purified MSC‐exosomes were taken up by NPCs and suppressed NPC apoptosis. The levels of miR‐21 were down‐regulated in apoptotic NPCs while MSC‐exosomes were enriched in miR‐21. The exosomal miR‐21 could be transferred into NPCs and alleviated TNF‐α induced NPC apoptosis by targeting phosphatase and tensin homolog (PTEN) through phosphatidylinositol 3‐kinase (PI3K)‐Akt pathway. Intradiscal injection of MSC‐exosomes alleviated the NPC apoptosis and IVD degeneration in the rat model. In conclusion, MSC‐derived exosomes prevent NPCs from apoptotic process and alleviate IVD degeneration, at least partly, via miR‐21 contained in exosomes. Exosomal miR‐21 restrains PTEN and thus activates PI3K/Akt pathway in apoptotic NPCs. Our work confers a promising therapeutic strategy for IVD degeneration. INTRODUCTION Low back pain is a highly prevalent condition and the leading cause of years lived with disability worldwide 1. A widely recognized contributor to low back pain is intervertebral disc (IVD) degeneration, which is the major cause of a series of lumbar degenerative disc diseases. IVD comprises the inner nucleus pulposus (NP) and surrounded annulus fibrosus (AF). The NP is a hydrated gelatinous tissue and the major functional composition of the IVD to confront diverse external mechanical stimuli. Nucleus pulposus cells (NPCs) are the main type of cells residing in the NP and responsible for synthesizing and maintaining the gelatinous extracellular matrix. IVD degeneration is characterized by loss of NPCs and extracellular matrix. Increased levels of inflammatory cytokines such as tumour necrosis factor‐a (TNF‐α) have been observed in degenerated IVD tissue and proven to induce excessive NPC apoptosis and resultant IVD degeneration 2, 3, 4, 5, 6. Thus, it is necessary to find an effective way to inhibit NPC apoptosis triggered by inflammatory cytokines. There has been great interest in utilizing MSCs transplantation as a potentially effective strategy for the treatment of IVD degeneration 7, 8. The effects of transplanted MSCs are partly because of their ability to mitigate NPC apoptosis 9. However, the underlying mechanism of this therapeutic process has not been fully explained 10. The direct differentiation of MSCs and the interaction between MSCs and NPCs with direct cell contact have been implicated in the therapeutic benefits 11, 12, 13. Meanwhile, emerging evidence has suggested the role of indirect paracrine effect by MSCs in stimulating intrinsic reparative potential of NPCs 14, 15. A recent study has found extensive transfer of vesicles between MSCs and NPCs 16. Nevertheless, what these vesicles contain, and whether their delivery is a potentially mechanism underlying MSC‐induced repair of NPCs remain elusive. Recently, accumulating evidence has demonstrated that MSCs released a type of specialized extracellular vesicles termed exosomes to provide therapeutic benefits 17. Exosomes are membranous nano‐sized vesicles secreted by a variety of cells, merging their membrane contents into the recipient cell membrane and transferring factors into the recipient cells. They have been increasingly reported as the principal therapeutic agent mediating MSCs paracrine action that underpins the therapeutic capabilities of MSCs in inhibiting apoptosis, reducing injury and/or promoting repair in the recipient cells 18. Thus, MSC‐secreted exosomes (MSC‐exosomes) are likely implicated in regulating apoptosis in NPCs. MSC‐exosomes carry a complex cargo of nucleic acids, proteins and lipids, with abundant miRNAs 19, and transfer these contents into the recipient cells, rationalizing potential applications of MSC‐exosomes as an alternative, cell‐free therapy 20. These exosomes‐delivered effectors, particularly miRNAs, can provide an effective therapeutic method of attenuating the recipient cell apoptosis 21, 22. miRNAs have considerable potential to be a research focus for prevention and treatment of IVD degeneration, especially for targeting promotion or suppression of NPC apoptosis 5, 23, 24, 25, 26, 27, 28. As a possible mediator of MSC‐exosomes and NPC apoptosis, exosomal miRNAs have therapeutic potential for NPC apoptosis and deserve to be further explored. Here, we explored the protective effect of MSC‐exosomes on NPCs in a cell and rat model, and specifically investigated the regulatory effect of miRNAs in MSC‐exosomes and associated mechanisms for NPC apoptosis. MATERIALS AND METHODS Cell isolation and culture Human bone marrow aspirates and NP tissue samples were obtained from five separate patients (age 32.8 ± 8.3) undergoing spine surgery because of burst thoracolumbar fracture to insure that the results were not donor specific (Table 1). The experimental protocol was approved by the institutional review board with informed consent from the patients. The NP tissues were treated with 0.25% pronase (Sigma‐Aldrich, Louis, MO, USA) for 30 min. and 0.2% collagenase type II (Invitrogen, Carlsbad, CA, USA) for 4 hrs at 37°C. The digest was filtered through a 70‐μm pore size mesh and then cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Grand Island, NY, USA) with 10% foetal bovine serum (FBS; Invitrogen), 1% penicillin–streptomycin (Sigma‐Aldrich), 2 mM glutamine (Sigma‐Aldrich) and 50 μg/mL L‐ascorbic acid (Sigma‐Aldrich) in T25 flasks at 37°C in 5% CO2. When grew to confluence, the cells were digested by 0.25% trypsin/1 mM EDTA and passed into bigger flasks for expansion. The NPCs from passage 4 or 5 were plated into experimental plates for all of the experiments. MSCs were isolated by density gradient centrifugation and adherence to tissue culture plastic. Cells were expanded in alpha‐minimum essential medium (α‐MEM, Gibco) containing 10% FBS and 1% penicillin–streptomycin. MSCs from passages 3 or 4 were used. Two independent MSC populations (2 different donors) were randomly selected and characterized by the expression of CD73, CD90 and CD105 and lack of expression of CD34 and CD45 using flow cytometry (Fig. S1). To obtain conditioned medium (CM), the medium was collected after 48 hrs of incubation with cells and centrifuged at 2000 g for 10 min. at 4°C. Supernatant was filtered through a 0.22‐μm filter to thoroughly remove the cellular debris. [Table: MSCs and NPCs donors used for this study] Exosomes isolation MSC‐exosomes isolation procedures were performed as previously described with some modifications 29. Briefly, MSCs were switched to OptiMEM (Invitrogen) and conditioned for 48 hrs before exosomes isolation. Culture supernatant was harvested by centrifugation at 300 g for 10 min. at 4°C to eliminate cells, at 2000 g for 20 min. to obtain apoptotic body and at 20,000 g for 30 min. to obtain microvesicles. At each step, the supernatant was transferred to new tubes and the pellets were immediately resuspended in phosphate‐buffered saline (PBS). The remaining supernatant was